About C the Signs
C the Signs is a company based in London (United Kingdom) founded in 2016 by Bhavagaya Bakshi and Miles Payling.. C the Signs has raised $14.92 million across 3 funding rounds from investors including Khosla Ventures. The company has 17 employees as of April 30, 2021. C the Signs offers products and services including Cancer Prediction System. C the Signs operates in a competitive market with competitors including Atrys, Inspirata, EDP Biotech Corporation, inveox and Nanovery, among others.
- Headquarter London, United Kingdom
- Employees 17 as on 30 Apr, 2021
- Founders Bhavagaya Bakshi, Miles Payling
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name C The Signs Limited
- Date of Incorporation 22 Mar, 2017
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.92 M (USD)
in 3 rounds
-
Latest Funding Round
$8 M (USD), Series A
Jan 30, 2025
- Investors
-
Employee Count
17
as on Apr 30, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of C the Signs
C the Signs offers a comprehensive portfolio of products and services, including Cancer Prediction System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI tool that identifies cancer risks and suggests tests for early detection.
Funding Insights of C the Signs
C the Signs has successfully raised a total of $14.92M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $8 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $8.0M
-
First Round
First Round
(27 Aug 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2025 | Amount | Series A - C the Signs | Valuation | Khosla Ventures |
|
| Oct, 2021 | Amount | Series A - C the Signs | Valuation |
investors |
|
| Aug, 2017 | Amount | Seed - C the Signs | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in C the Signs
C the Signs has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Khosla Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by C the Signs
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - C the Signs
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
C The Signs Comparisons
Competitors of C the Signs
C the Signs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Atrys, Inspirata, EDP Biotech Corporation, inveox and Nanovery, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diagnostic and therapeutic services catering to cancer
|
|
| domain | founded_year | HQ Location |
Digital pathology solutions for cancer diagnostics are developed by Inspirata.
|
|
| domain | founded_year | HQ Location |
Offers online purchase of diagnostic test kits and lab appointment scheduling services.
|
|
| domain | founded_year | HQ Location |
Automated solutions for biopsy sample preparation in laboratories are provided.
|
|
| domain | founded_year | HQ Location |
Nanobots are developed for cancer diagnosis through bloodstream administration.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on C The Signs
Frequently Asked Questions about C the Signs
When was C the Signs founded?
C the Signs was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Where is C the Signs located?
C the Signs is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Who is the current CEO of C the Signs?
Bhavagaya Bakshi is the current CEO of C the Signs. They have also founded this company.
Is C the Signs a funded company?
C the Signs is a funded company, having raised a total of $14.92M across 3 funding rounds to date. The company's 1st funding round was a Seed of $51.5K, raised on Aug 27, 2017.
How many employees does C the Signs have?
As of Apr 30, 2021, the latest employee count at C the Signs is 17.
What does C the Signs do?
C the Signs was founded in 2016 in London, United Kingdom, within the health technology sector. A cancer prediction system is offered by the platform to analyze patient data and identify risks at early, curable stages. Services include prevention, screening, point-of-care assessment, and surveillance. Risk factors such as signs, symptoms, clinical markers, genetics, lifestyle, and environmental elements are combined in a data-driven approach to support patient identification.
Who are the top competitors of C the Signs?
What products or services does C the Signs offer?
C the Signs offers Cancer Prediction System.
Who are C the Signs's investors?
C the Signs has 1 investor. Key investors include Khosla Ventures.